Premier Perspectives The blog for insider insights in clinical development Development Strategy Advancing from Research to Development: What Can Go Wrong? By Alain Guimond May 19, 2023 Featured Posts Clinical ResearchPhase 1 - Phase 4 In Silico Modeling Unveils a New Era in Rare Disease Drug Development By Abie Ekangaki May 4, 2023 Clinical ResearchPhase 1 - Phase 4 Beyond Boundaries: Revolutionary CAR-T Therapies Pave Way to Conquer Solid Tumors By Ayesha Pandit April 24, 2023 Premier Voices Podcast Conversations with Premier's subject matter experts PREMIER VOICES #15 Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients PREMIER VOICES #13 Early-Phase Oncology – Emerging From the Crisis & Innovating for the Future PREMIER VOICES #12 Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials? PREMIER VOICES #11 Statistical Considerations in the Wake of COVID-19 PREMIER VOICES #10 COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster Premier Voices #8 Engaging Patients in Clinical Trials w/ Alan Thomas Premier Voices #7 Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me) Premier Voices #6 Operationalizing the New MDR With Janet Kube (Part 2) Premier Voices #5 Operationalizing the New MDR With Janet Kube (Part 1) Premier Voices #4 The Placebo Problem Part 2 With Michael Kuss Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 To Placebo or Not to Placebo? The Great Debate in Rare Disease Trials By Jaclyn Brown March 31, 2023 Clinical ResearchPhase 1 - Phase 4 Realizing the Full Value of Patient Centricity in Rare Disease: 5 Ways to Maximize Your Engagement Efforts By Kris O'Brien March 27, 2023 Clinical ResearchPhase 1 - Phase 4 At the Intersection of Rare Disease and Precision Medicine: A Road to Growth By Adam Bloomfield March 7, 2023 Clinical ResearchPhase 1 - Phase 4 Rare Disease Patients as Partners: Value Beyond Enrollment By Nicole Carswell March 6, 2023 Clinical ResearchPhase 1 - Phase 4 Charting the Path: How Patient and Caregiver Journeys Guide Rare Disease Study Design By Kris O'Brien February 15, 2023 Clinical ResearchPhase 1 - Phase 4 9 Tips for Designing and Operationalizing Early-Stage Precision Oncology Studies By Abie Ekangaki February 2, 2023 1 2 3 … 50 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayKey Considerations When Designing a Phase 1...7 Questions About Clinical Evaluations for MDR